Ozempic Shot Cost: Pricing & Dosing Guide

Last reviewed: May 31, 2026

Last updated: May 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

One Ozempic injection pen typically costs $800–$1,400 without insurance, depending on the dose strength (0.25 mg, 0.5 mg, 1 mg, or 2 mg). The full per-injection cost depends on whether the pen is used once weekly for 4 weeks or adjusted based on clinical tolerance and response.

For patients exploring GLP-1 therapy, understanding the true cost per dose—including insurance dynamics, dosing patterns, and alternative formulations—is essential to making informed treatment decisions. PlexusDx focuses on precision wellness by helping patients evaluate both branded and compounded options within their budget and clinical context.

Ozempic Injection Pricing: What Determines Your Actual Cost

Ozempic pen prices fluctuate based on pharmacy, geographic location, and insurance formulary placement. Without insurance, retail prices range $800–$1,400 per 4-week supply. Copays for insured patients vary significantly: some plans cover Ozempic at $25–$50 per injection, while others require higher copays or step therapy.

List price alone does not reflect your out-of-pocket expense. Patient assistance programs, manufacturer rebates, and pharmacy discount cards can reduce costs by 20–50%. Understanding your specific insurance tier and exploring available copay coupons is critical before starting treatment.

Ozempic Dosing Schedule and Per-Injection Cost Breakdown

Ozempic is administered as a once-weekly subcutaneous injection. Standard titration begins at 0.25 mg weekly, increasing to 0.5 mg, 1 mg, and up to 2 mg based on tolerability and glycemic response. Each dose strength carries different retail and insurance costs, affecting your per-injection expense.

Dose Strength	Typical Retail Price (per pen)	Weekly Injection Schedule	4-Week Supply Cost
0.25 mg	$800–$900	Once weekly	$800–$900
0.5 mg	$900–$1,000	Once weekly	$900–$1,000
1 mg	$1,100–$1,250	Once weekly	$1,100–$1,250
2 mg	$1,200–$1,400	Once weekly	$1,200–$1,400

Insurance Coverage, Formulary Status, and Prior Authorization

Most major insurers cover Ozempic for type 2 diabetes but may place it on higher formulary tiers, requiring prior authorization or step therapy (trying other medications first). Medicare Part D coverage varies by plan; some exclude GLP-1 medications entirely, while others offer tiered copays or quantity limits.

Off-label use for weight management is rarely covered by insurance, shifting costs entirely to patients. Checking your formulary status and contacting your insurer before starting treatment can prevent unexpected bills and clarify whether prior authorization is required.

Comparing Branded Ozempic with Compounded Semaglutide: Cost and Clinical Context

Compounded semaglutide offers a lower-cost alternative to branded Ozempic, typically ranging $179–$229 per month from licensed 503A pharmacies. Compounded formulations contain the same active ingredient but are prepared in regulated compounding facilities rather than manufactured by the pharmaceutical company.

Compounded semaglutide is not FDA-approved but is derived from FDA-approved semaglutide under strict pharmacy regulations. Cost savings are significant—50–70% less than branded Ozempic—but availability, supply consistency, and insurance coverage differ. A qualified healthcare provider can help determine if a compounded option aligns with your clinical needs and budget.

Genetic Predispositions and Personalized Response to GLP-1 Therapy

Individual genetic variations in GLP-1 receptor expression, GIPR signaling, and metabolic pathways may influence how a patient responds to semaglutide or tirzepatide therapy. Genetic predispositions alone do not determine medication response but can provide clinical context for personalized treatment conversations.

PlexusDx's Precision Peptide Genetic Test ($99 as an add-on or $298 standalone) analyzes key variants in GLP1R, GIPR, FTO, and MC4R pathways. These predispositions may help inform whether higher-dose therapy, combination formulations, or alternative agents warrant discussion with your provider—potentially impacting long-term treatment strategy and cost-effectiveness.

How PlexusDx Supports a More Personalized Approach

PlexusDx recognizes that GLP-1 therapy cost extends beyond the per-injection price to include onset speed, adherence, and individual metabolic response. Genetic insights into peptide pathway function may help provide context for why some patients achieve robust weight or glucose outcomes on lower doses while others require titration—a factor that directly affects total treatment cost over time.

The Precision Peptide Genetic Test reveals predispositions in GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 pathways. These variants can support a more informed conversation with your provider about expected response patterns, optimal dosing strategy, and whether compounded or branded formulations align with your genetic and clinical profile.

Understanding both the upfront cost of Ozempic and your individual genetic predispositions in GLP-1 and GIPR signaling enables a more complete cost-benefit analysis. This information, interpreted with a qualified healthcare provider, can guide decisions about branded versus compounded options and expected treatment duration, ultimately supporting more efficient and personalized therapy planning.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $229-$509/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.